Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adallen Nutrition is a specialized medical nutrition company dedicated to the development and commercialization of advanced nutritional products for individuals with rare inherited metabolic disorders. The company focuses on conditions such as Phenylketonuria (PKU), Tyrosinemia, and Maple Syrup Urine Disease (MSUD), providing amino acid-based medical foods that serve as essential dietary management tools. Founded by industry veterans with deep expertise in the metabolic space, Adallen Nutrition emphasizes improving the palatability, convenience, and nutritional profile of medical formulas. Their mission is to enhance patient adherence and overall quality of life for the metabolic community through innovative, patient-centric solutions. The company's portfolio includes specialized formulas designed to meet the unique physiological needs of patients across different life stages.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adallen Nutrition.